SBLENDORIO GLENN received a stock award from INTERCEPT PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/25/2023ACC: 0001104659-23-064845
Director
Since Jun 2019
+20.66K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
20.66K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.11K
Price / share
—
Trade value
—
% of position
34.6%
5/24/2023
23.45K→31.56K
Total
Net shares
+8.11K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/24/2023 | A · Award | +8.11K | — | — | 34.6% | 23.45K | 31.56K |
| Total | +8.11K | $0.00 | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
12.55K shares
Shares
+12.55K
Strike price
9.17
Held after
12.55K
Exercisable
—
5/24/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock12.55K shares | 5/24/2023 | A · Award | +12.55K | 9.17 | — | 12.55K |